Adenovir Pharma AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Adenovir Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011877
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adenovir Pharma AB (Adenovir Pharma) is a drug development company that develops antiviral medicinal solutions for the treatment of infectious diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis affecting the eyes. The company’s products are eye drops which acts outside the human cells that reduce the risk of developing viral resistance. Its APD-209 is topical pharmaceutical product that prevents EKC-causing adenoviruses from binding to the receptors in the human eye. The company partners with pharma companies to develop new products. Adenovir Pharma is headquartered in Helsingborg, Sweden.

Adenovir Pharma AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adenovir Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Adenovir Pharma Raises US$2.4 Million In Venture Financing 10
Adenovir Pharma Raises US$1.4 Million In Venture Financing 11
Adenovir Pharma Raises US$1.7 Million In Venture Financing 12
Equity Offering 13
Adenovir Pharma Raises USD1.5 Million in Rights Offering of Shares 13
Adenovir Pharma AB – Key Competitors 14
Adenovir Pharma AB – Key Employees 15
Adenovir Pharma AB – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Key Facts 2
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adenovir Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adenovir Pharma AB, Deals By Therapy Area, 2011 to YTD 2017 8
Adenovir Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adenovir Pharma Raises US$2.4 Million In Venture Financing 10
Adenovir Pharma Raises US$1.4 Million In Venture Financing 11
Adenovir Pharma Raises US$1.7 Million In Venture Financing 12
Adenovir Pharma Raises USD1.5 Million in Rights Offering of Shares 13
Adenovir Pharma AB, Key Competitors 14
Adenovir Pharma AB, Key Employees 15

★海外企業調査レポート[Adenovir Pharma AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Career Education Corporation:企業の戦略・SWOT・財務情報
    Career Education Corporation - Strategy, SWOT and Corporate Finance Report Summary Career Education Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務情報
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ocado Group Plc:企業の戦略・SWOT・財務分析
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Seair Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Seair Inc, doing business as Dover Water Solutions, is a clean technology company that carries out research and development, production and sale of gas diffusion technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Enterprise Diversified Inc (SYTE):企業の財務・戦略的SWOT分析
    Summary Enterprise Diversified Inc (Enterprise Diversified), formerly Sitestar Corp, is a technology company that offers asset management, home services, internet, and real estate programs. The company offers consumer and business-grade internet access, wholesale managed modem services for downstrea …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • Owens & Minor Inc (OMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Carnival Group International Holdings Ltd:企業のM&A・事業提携・投資動向
    Carnival Group International Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carnival Group International Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Yokogawa Electric Corporation (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corporation (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • RPC Astrapak:企業の戦略的SWOT分析
    RPC Astrapak - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報
    Summary Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company produces tablet, capsule, and injection formulations and active pharmaceutical ingredients, among others. …
  • BioCision LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company’s products include cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell thawing s …
  • Galp Energia SGPS SA (GALP)-石油・ガス分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …
  • Minnkota Power Cooperative Inc:発電所・企業SWOT分析
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Quorum Health Corp (QHC):企業の財務・戦略的SWOT分析
    Summary Quorum Health Corp (QHC) is a healthcare service provider that offers outpatient services. The center owns and leases hospitals and outpatient centers across the US. Its hospitals provides general hospital health-care services including general acute care, emergency room, general and special …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆